http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2636622-C2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fac028551c69db3898f3710274a4e761 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7024 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7024 |
filingDate | 2013-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2017-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fdbd530b60c373312df62cb0bcb0e2a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36c17ce4badef4fa10b51ebde560cbce |
publicationDate | 2017-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2636622-C2 |
titleOfInvention | Introduction of erythorane or its pharmaceutically acceptable salts for orthomyxoviral infections treatment |
abstract | FIELD: medicine. n SUBSTANCE: methods of the invention include administration of a therapeutically effective amount of erythorane or a pharmaceutically acceptable salt thereof to the infected patient. n EFFECT: application of the inventions allows to limit the duration of infection by reducing the titer of viruses, reducing the production of influenza-induced cytokines, reducing the level of liver enzymes and oxidized phospholipids. n 34 cl, 13 dwg, 1 tbl |
priorityDate | 2012-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 231.